Identification of complement receptor one (CR1) polymorphisms in West Africa

被引:0
|
作者
JM Moulds
L Kassambara
JJ Middleton
M Baby
I Sagara
A Guindo
S Coulibaly
D Yalcouye
DA Diallo
L Miller
O Doumbo
机构
[1] University of Texas-Houston Medical School,
[2] University of Mali,undefined
[3] National Institute of Allergy and Infectious Disease,undefined
[4] NIH,undefined
来源
Genes & Immunity | 2000年 / 1卷
关键词
malaria; blood groups; complement receptors;
D O I
暂无
中图分类号
学科分类号
摘要
Complement receptor one (CR1) is a ligand for the rosetting of Plasmodium falciparum infected red cells with uninfected cells. Since CR1 exhibits three known polymorphisms, we studied European-Americans (n = 112) and African-Americans (n = 330) and Malians (n = 158) to determine if genetic differences existed in an area endemic for malaria that could offer a survival advantage. The frequencies of Knops blood group phenotypes McC(b+) and Sl(a−) were greatly increased in Africans vs Europeans. Although the frequency of McC(b+) was similar between Africans from the USA or Mali, the Sl(a−) phenotype was significantly higher in Mali (39% vs 65%, respectively). There was an increased frequency of the largest size (250 kD) of CR1 in Mali, but this did not differ significantly from the USA (P = 0.09). Both cohorts of Africans had higher expression of red cell CR1 than European-Americans but this showed little difference between the USA and Mali groups. Thus, the most important CR1 polymorphism relevant to rosetting of malaria infected cells appears to be the Knops blood group.
引用
收藏
页码:325 / 329
页数:4
相关论文
共 50 条
  • [31] Rapid purification of human complement receptor type 1 (CD35, CR1)
    Seya, T
    Matsumoto, M
    Hatanaka, M
    Okada, M
    Masaki, T
    Iida, K
    JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1996, 32 (02): : 69 - 76
  • [32] Complement receptor 1 (CR1, CD35) binds CpG-DNA
    Lepse, N.
    Van Bommel, P.
    Daha, M. R.
    Kallenberg, C. G. M.
    Heeringa, P.
    MOLECULAR IMMUNOLOGY, 2011, 48 (14) : 1687 - 1687
  • [33] Complement receptor 1 gene (CR1) intragenic duplication and risk of Alzheimer's disease
    Kucukkilic, Ezgi
    Brookes, Keeley
    Barber, Imelda
    Guetta-Baranes, Tamar
    Morgan, Kevin
    Hollox, Edward J.
    HUMAN GENETICS, 2018, 137 (04) : 305 - 314
  • [34] Mutations in complement receptor 1 (CR1) gene in recurrent thrombotic thrombocytopenic purpura (TTP)
    Pianetti, G
    Brioschi, S
    Todeschini, M
    Porrati, F
    Bresin, E
    Caprioli, J
    Bucchioni, S
    Remuzzi, G
    Noris, M
    MOLECULAR IMMUNOLOGY, 2006, 43 (1-2) : 168 - 168
  • [35] DIFFERENCES IN TRANSMISSION INTENSITIES OF FALCIPARUM MALARIA AFFECT THE FREQUENCY OF HUMAN COMPLEMENT RECEPTOR 1 (CR1) POLYMORPHISMS IN NORTH-EASTERN TANZANIA
    Hansson, Helle H.
    Vestergaard, Lasse S.
    Lemnge, Martha M.
    Mmbando, Bruno P.
    Enevold, Anders
    Schousboe, Mette L.
    Lusingu, John P.
    Theander, Thor G.
    Bygbjerg, Ib C.
    Alifrangis, Michael
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (06): : 96 - 96
  • [36] Complement factor H (CfH) on rodent podocytes is the functional counterpart to human podocyte complement receptor 1 (CR1)
    Alexander, Jessy J.
    Wang, Ying
    Chang, Anthony
    Haas, Mark
    Minto, Andrew
    Quigg, Richard J.
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 149 - 149
  • [37] Complement receptor 1 gene (CR1) intragenic duplication and risk of Alzheimer’s disease
    Ezgi Kucukkilic
    Keeley Brookes
    Imelda Barber
    Tamar Guetta-Baranes
    Kevin Morgan
    Edward J. Hollox
    Human Genetics, 2018, 137 : 305 - 314
  • [38] Complement coating of erythrocytes is reduced following their interaction with neutrophils in vitro without loss of complement receptor 1 (CR1)
    Imrie, HJ
    Jones, DRE
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01): : 217 - 222
  • [39] Mechanistic insights into complement pathway inhibition by duplication of Complement Receptor 1 (CR1) long homologous repeat domains
    Wymann, Sandra
    Nair, Anup
    Ewert, Svenja
    Powers, Glenn
    Morelli, Adriana Baz
    Rowe, Tony
    Hardy, Matthew
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 197 - 197
  • [40] Identification of amino acids specific for decay accelerating activity (DAA) in complement receptor type 1 (CR1; CD35).
    Krych, M
    Hauhart, R
    Hourcade, D
    Subramanian, B
    Atkinson, J
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1524 - 1524